Tag: biomedical
-
Protein Made by Synthetic Bacteria with Expanded DNA
An academic-industry lab team produced a synthetic protein from an engineered bacteria, with DNA modified to expand its number of chemical coding components.
-
Marine Animal Venom Studied for Pain Drugs
A medical research team is investigating the chemistry in venom from snail-like marine animals to discover natural alternative drugs for pain.
-
Artificial Muscles Designed for Soft Robotics
Engineering researchers created artificial muscles for robotics using principles from origami, or Japanese paper folding, with high strength and low-cost materials.
-
Trial to Test Ultrasound/MRI for Brain Cancer
A developer of a technology that combines ultrasound and MRI scans plans to begin a clinical trial of its techniques to improve delivery of drugs to treat a form of brain cancer.
-
Large-Scale Genome Editing Technology in Development
Two biotechnology companies are creating an automated process for delivering large, complex genetic cargoes into cells for genome editing.
-
Rapid DNA, RNA Capture Technique Devised
Researchers in Australia developed a simple and inexpensive dipstick technique that captures and purifies specimen samples for genetic analysis in about 30 seconds.
-
Genome Editing Enhances CAR T-Cells to Fight Cancer
A process using genome editing is shown to bolster cancer-fighting properties of T-cells from the immune system already modified to attack cancer cells.
-
Simple Blood Test System Detects Brain Injuries
An engineering team at Purdue University designed a system that detects indicators of traumatic brain injuries in lab tests with one or two drops of blood.
-
Biotech, Cancer Center Partner on T-Cell Research
A developer of cancer diagnostics and treatments is collaborating with Moffitt Cancer Center to advance therapies for ovarian cancer with T-cells from the immune system.
-
Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal
Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies.